RBS — Ramdevbaba Solvent Income Statement
0.000.00%
- IN₹2.07bn
- IN₹3.07bn
- IN₹6.98bn
Annual income statement for Ramdevbaba Solvent, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 4,239 | 5,829 | 6,978 |
Cost of Revenue | |||
Gross Profit | 704 | 823 | 965 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 4,149 | 5,709 | 6,815 |
Operating Profit | 90.5 | 119 | 163 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 86 | 92 | 171 |
Provision for Income Taxes | |||
Net Income After Taxes | 61.7 | 65.9 | 130 |
Net Income Before Extraordinary Items | |||
Net Income | 61.7 | 65.9 | 130 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 61.7 | 65.9 | 130 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 2.78 | 2.98 | 5.88 |
Dividends per Share |